Anurag Sharadendu

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Epix Delaware, Inc., Epix Pharmaceuticals, Inc., Galenea Corp.. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anurag Sharadendu. Retrieved from https://idiyas.com/inventor/anurag-sharadendu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 14.6

ph-index = 4

Forward Citations = 74(Granted Patents)

Location History:

Salem, NH (US) (2006)
Washington, DC (US) (2009 - 2011)
Bedford, MA (US) (2009 - 2013)

Company Filing History:

Epix Pharmaceuticals, Inc.

Predix Pharmaceuticals Holdings, Inc.

patent

5. 1 out of 834,570

Other

patents

Years Active: 2006-2013

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8604021 - Substituted arylamine compounds and methods of treatment (2013-12-10),

2. 7968538 - Substituted arylamine compounds and methods of treatment (2011-06-28),

3. 7919519 - S1P receptor modulating compounds and use thereof (2011-04-05),

4. 7855193 - S1P receptor modulating compounds and use thereof (2010-12-21),

5. 7612078 - Piperidinylamino-thieno[2,3-D] pyrimidine compounds (2009-11-03),

6. 7491727 - Arylpiperazinyl compounds (2009-02-17),

7. 7488731 - Arylpiperazinyl compounds (2009-02-10),

8. 7153858 - Arylpiperazinyl compounds (2006-12-26),

9. 7030240 - Piperidinylamino-thieno[2,3-d] pyrimidine compounds (2006-04-18),

Title: Anurag Sharadendu: Innovator in Pharmaceutical Compounds

Introduction

Anurag Sharadendu is a notable inventor based in Bedford, MA, who has made significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has focused on developing innovative compounds that address various physiological and psychological conditions.

Latest Patents

Among his latest patents are the substituted arylamine compounds and methods of treatment, which relate to 5-HT receptor antagonists. These novel arylamine compounds and their pharmaceutical compositions are designed for the treatment, modulation, and prevention of conditions associated with serotonin action. This includes addressing obesity and obesity-related disorders such as cardiovascular disease, digestive disease, respiratory disease, cancer, and type II diabetes. Additionally, his work extends to psychological disorders, including schizophrenia.

Career Highlights

Anurag has worked with prominent companies in the pharmaceutical industry, including Epix Delaware, Inc. and Epix Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Some of his notable coworkers include Oren Becker and Srinivasa Rao Cheruku, who have collaborated with him on various projects throughout his career.

Conclusion

Anurag Sharadendu's innovative work in developing pharmaceutical compounds showcases his dedication to improving health outcomes. His contributions to the field are significant and continue to impact the treatment of various medical conditions.

Profile summary based on public USPTO records.